LTF and hepatocellular carcinoma: Previous studies by Gollaet al.27 showed that doxorubicin when encapsulatedin lactoferrin nanoparticles did not have any significant toxicityin hepatocellular cancer animals despite the high toxicity of freedoxorubicin.